E. Donnall Thomas

Active 1949–2022

Also published as
E. DONNALL THOMAS
153
Papers
44,053
Citations
106
h-index
153
i10-index

Citations

Citations per year for E. Donnall Thomas1967: 4 citations1968: 2 citations1969: 4 citations1970: 8 citations1971: 18 citations1972: 21 citations1973: 9 citations1974: 42 citations1975: 50 citations1976: 59 citations1977: 86 citations1978: 76 citations1979: 83 citations1980: 122 citations1981: 127 citations1982: 191 citations1983: 242 citations1984: 175 citations1985: 185 citations1986: 365 citations1987: 222 citations1988: 167 citations1989: 185 citations1990: 271 citations1991: 156 citations1992: 159 citations1993: 183 citations1994: 216 citations1995: 166 citations1996: 200 citations1997: 238 citations1998: 248 citations1999: 294 citations2000: 318 citations2001: 303 citations2002: 402 citations2003: 295 citations2004: 245 citations2005: 251 citations2006: 238 citations2007: 216 citations2008: 217 citations2009: 187 citations2010: 172 citations2011: 160 citations2012: 129 citations2013: 120 citations2014: 124 citations2015: 124 citations2016: 108 citations2017: 77 citations2018: 89 citations2019: 323 citations2020: 327 citations2021: 251 citations2022: 191 citations2023: 111 citations2024: 225 citations2025: 69 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,360 citing papers, 36.5% of this breakdownUnited Kingdom: 620 citing papers, 6.7% of this breakdownGermany: 619 citing papers, 6.7% of this breakdownFrance: 533 citing papers, 5.8% of this breakdownItaly: 502 citing papers, 5.5% of this breakdownNetherlands: 353 citing papers, 3.8% of this breakdownCanada: 275 citing papers, 3% of this breakdownSpain: 262 citing papers, 2.8% of this breakdownJapan: 219 citing papers, 2.4% of this breakdownSweden: 209 citing papers, 2.3% of this breakdownAustralia: 207 citing papers, 2.3% of this breakdownChina: 202 citing papers, 2.2% of this breakdown
0%36.5%Other 20%

Fields

  • Medicine84.9%
  • Immunology and Microbiology6.9%
  • Biochemistry, Genetics and Molecular Biology6.2%
  • Nursing0.4%
  • Engineering0.2%
  • Mathematics0.2%
  • Other1.2%

Topics

  • Hematopoietic Stem Cell Transplantation15.9%
  • Cytomegalovirus and herpesvirus research4.9%
  • Immune Cell Function and Interaction4.3%
  • Acute Myeloid Leukemia Research4.1%
  • T-cell and B-cell Immunology3.8%
  • Acute Lymphoblastic Leukemia research3.2%
  • Other63.8%

Coauthors

All papers

Open in search
  1. CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S

    Authors: , , , , , , , - Transplantation 1974 cited by 3,714

  2. Intravenous Infusion of Bone Marrow in Patients Receiving Radiation and Chemotherapy

    Authors: , , , - New England Journal of Medicine 1957 cited by 1,194

  3. Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 166

  4. Chronic graft-versus-host syndrome in man

    Authors: , , , , , , , , , - The American Journal of Medicine 1980 cited by 2,427

  5. Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory Syncytial Virus Fusion

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Medicinal Chemistry 2021 cited by 75

  6. A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein

    Authors: , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2019 cited by 88

  7. Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 1986 cited by 1,456

  8. Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor

    Authors: , , , , , , - New England Journal of Medicine 1995 cited by 1,792

  9. Effect of HLA Compatibility on Engraftment of Bone Marrow Transplants in Patients with Leukemia or Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 1989 cited by 685

  10. Development of a database for the rapid and accurate routine identification of Achromobacter species by matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry (MALDI-TOF MS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2020 cited by 38

  11. Bone-Marrow Transplantation

    Authors: , , , , , , , , - New England Journal of Medicine 1975 cited by 1,711

  12. SUPRALETHAL WHOLE BODY IRRADIATION AND ISOLOGOUS MARROW TRANSPLANTATION IN MAN*†

    Authors: , , , , - Journal of Clinical Investigation 1959 cited by 422

  13. Practical Management of the Venetoclax-Treated Patient in Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia

    Authors: , , , , - Journal of the Advanced Practitioner in Oncology 2022 cited by 32

  14. Bone-Marrow Transplantation

    Authors: , , , , , , , , - New England Journal of Medicine 1975 cited by 1,185

  15. Regimen-related toxicity in patients undergoing bone marrow transplantation.

    Authors: , , , , , , - Journal of Clinical Oncology 1988 cited by 878

  16. Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

    Authors: , , , , , , , , , , , - New England Journal of Medicine 1979 cited by 646

  17. APLASTIC ANAEMIA TREATED BY MARROW TRANSPLANTATION

    Authors: , , , , , , , , , - The Lancet 1972 cited by 254

  18. Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution

    Authors: , , , , , , , - Blood 2004 cited by 93

  19. Direct Evidence for a Bone Marrow Origin of the Alveolar Macrophage in Man

    Authors: , , , , - Science 1976 cited by 378

  20. ASSOCIATION OF ANDROGENIC-ANABOLIC STEROID THERAPY WITH DEVELOPMENT OF HEPATOCELLULAR CARCINOMA

    Authors: , , , , , , - The Lancet 1972 cited by 376

  21. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma

    Authors: , , , , , , , - Human Immunology 1990 cited by 345

  22. Ovarian function following marrow transplantation for aplastic anemia or leukemia.

    Authors: , , , , , , , , , - Journal of Clinical Oncology 1988 cited by 325

  23. Aplastic Anemia

    Authors: , , - New England Journal of Medicine 1982 cited by 304

  24. Long-Term Follow-Up of a Randomized Trial of Two Irradiation Regimens for Patients Receiving Allogeneic Marrow Transplants During First Remission of Acute Myeloid Leukemia

    Authors: , , , , , - Blood 1998 cited by 161